|
(S)-1-Cyclopropylethylamine
|
(S)-1-環(huán)丙基乙胺
|
195604-39-8
|
|
FT-113
|
FT113
|
1630808-89-7
|
|
4-Fluoro-3-hydroxyphenylboronic acid
|
4-氟-3-羥基苯硼酸
|
913835-74-2
|
|
DSP-2230
|
DSP-2230
|
1233231-30-5
|
|
Nifeviroc
|
Nifeviroc
|
934740-33-7
|
|
UMB298
|
UMB298
|
2266569-73-5
|
|
Tranexamic acid
|
氨甲環(huán)酸
|
1197-18-8
|
|
4,6-Dichloro-1H-pyrazolo[4,3-c]pyridine
|
4,6-二氯-1H-吡唑并[4,3-c]吡啶
|
1256794-28-1
|
|
Monohydroxy Netupitant
|
奈妥匹坦雜質(zhì)A
|
910808-12-7
|
|
Capecitabine
|
卡培他濱
|
154361-50-9
|
|
PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID
|
吡唑[1,5-A]嘧啶-3-羧酸
|
25940-35-6
|
|
Ketohexokinase inhibitor 1
|
PF-06835919
|
2102501-84-6
|
|
CC-90001
|
CC90001
|
1403859-14-2
|
|
LTT-462
|
ERK-IN-1 (COMPOUND B)
|
1715025-32-3
|
|
AHR antagonist 3
|
AHR antagonist 3
|
2242464-44-2
|
|
(R)-1-Boc-2-azetidinemethanol
|
(R)-1-(叔丁氧羰基)-2-吖丁啶甲醇
|
161511-90-6
|
|
IACS-13909
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
|
Ethyl 5,5,5-trifluoro-2,4-dioxopentanoate
|
5,5,5-三氟-2,4-二氧代戊酸乙酯
|
893643-18-0
|
|
2,4-dichloro-6-methoxypyrimidine
|
2,4-二氯-6-甲氧基嘧啶
|
43212-41-5
|
|
Lixivaptan
|
利伐普坦
|
168079-32-1
|
|
tert-Butyl 5-bromoisoindoline-2-carboxylate
|
5-溴異吲哚啉-2-碳酸叔丁酯
|
201940-08-1
|
|
GSK3145095
|
GSK3145095
|
1622849-43-7
|
|
vanin-1 inhibitor
|
vanin-1 inhibitor
|
2173134-00-2
|
|
PXL007
|
YP001
|
1192171-69-9
|
|
PS-5505
|
PXS-5505二鹽酸鹽
|
2409964-23-2
|
|
3-AMino-2,2-difluoropropanoic acid hydrochlorid
|
3-氨基-2,2-二氟丙酸鹽酸鹽
|
1159825-06-5
|
|
Methyl 4-Amino-3-bromo-5-fluorobenzoate
|
甲基 4-氨基-3-溴-5-氟苯甲酸甲酯
|
1123171-91-4
|
|
N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide
|
2-乙酰氨基吡啶-4-硼酸頻那醇酯
|
1220220-21-2
|
|
(S)-Methyl 6-Hydroxy-2,3-dihydrobenzofuran-3-ylacetate
|
6-羥基-2,3-二氫苯丙呋喃-3-基乙酸-(S)-甲酯
|
1000414-38-9
|
|
7-Bromo-4-fluoro-1-indanone
|
7-溴-4-氟-2,3-二氫-1H-茚-1-酮
|
881189-73-7
|
|
6-benzyl 1-ethyl 6-azaspiro[2.5]octane-1,6-dicarboxylate
|
6-芐基-1-乙基6-氮雜螺[2.5]辛烷-1,6-二羧酸酯
|
147610-84-2
|
|
Lesinurad Impurity 3
|
雷西納德雜質(zhì)3
|
1384208-36-9
|
|
PF-06882961
|
PF-06882961
|
2230198-02-2
|
|
KL-1333
|
KL1333
|
1800405-30-4
|
|
PK68
|
PK68
|
2173556-69-7
|
|
GS-4361
|
GS-4361
|
2291164-02-6
|
|
BMS-615
|
BMS-615
|
2180127-82-4
|
|
MDR652
|
化合物MDR-652
|
1933528-96-1
|
|
PS-5505
|
(2Z)-3-氟-4-(8-喹啉磺?；?-2-丁烯-1-胺
|
2409963-83-1
|
|
BMS-986242
|
Benzamide, 4-chloro-N-[(1R)-1-[cis-4-(6-fluoro-4-quinolinyl)cyclohexyl]ethyl]-
|
1923844-48-7
|
|
(2,6-Dichloro-pyrimidin-4-yl)-dimethyl-amine
|
(2,6-二氯-嘧啶-4-基)-二甲胺
|
117077-93-7
|
|
3-cyclopropylpyrrolidine
|
3-環(huán)丙基-吡咯烷
|
1250004-31-9
|
|
GSK-2894631A
|
GSK-2894631A
|
2101626-26-8
|
|
BAY-2335218
|
CPD3504
|
2162982-11-6
|
|
Lesinurad Impurity Z
|
雷西納德雜質(zhì)Z
|
|
|
EC-5026
|
EC-5026
|
1809885-32-2
|
|
CTX-3648
|
PF-9363
|
2569009-58-9
|
|
(S)-beta-(4-Fluorophenyl)alaninol
|
(S)-3-(4-氟苯基)-B-氨基丙醇
|
228422-49-9
|
|
2-bromo-4-chloro-1-(difluoromethoxy)benzene
|
2-溴-4-氯-1-(二氟甲氧基)苯
|
1214348-81-8
|
|
2,3,6-Trichloro-4-(trifluoromethyl)pyridine
|
2,3,6-三氯-4-三氟甲基吡啶
|
81565-20-0
|
|
Seltorexant
|
JNJ-42847922
|
1293281-49-8
|
|
GSK-547
|
GSK547
|
2226735-55-1
|
|
NCC007
|
NCC007
|
|
|
CC-90011
|
CC-90011
|
2097523-60-7
|
|
NTP42
|
NTP-42
|
2055599-51-2
|
|
nAChR agonist1
|
化合物NACHR AGONIST 1
|
1394371-75-5
|
|
RBN-2397
|
RBN-2397
|
2381037-82-5
|
|
SHR0302
|
化合物SHR0302
|
1445987-21-2
|
|
AZD-5305
|
AZD-5305
|
2589531-76-8
|
|
Sisunatovir HCl
|
SISUNATOVIR HCL
|
1903763-83-6
|
|
tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride
|
2,7-二氮雜螺[3.5]壬烷-7-甲酸叔丁酯鹽酸鹽
|
1023301-84-9
|
|
Ethyl 3-Amino-2,2-difluoropropanoate Hydrochloride
|
2,2-二氟-3-氨基丙酸乙酯鹽酸鹽
|
1263284-04-3
|
|
N-Desmethyl Netupitant
|
奈妥匹坦雜質(zhì)B
|
290296-72-9
|
|
3-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenol
|
4-羥基-2-甲基苯硼酸頻呢醇酯
|
946427-03-8
|
|
4-ethyl-2-fluoroaniline
|
4-乙基-2-氟苯胺
|
821791-69-9
|
|
(2S)-3-[(tert-butoxy)carbonyl]-1,3-thiazolidine-2-carboxylic acid
|
(2S)-3-[(叔-丁氧基)羰基]-1,3-噻唑烷-2-羧酸
|
891192-95-3
|
|
RK-287107
|
RK-287107
|
2171386-10-8
|
|
LUT-014
|
LUT-014
|
2274819-46-2
|
|
VU6015929
|
VU6015929
|
|
|
Favipiravir(T-705)
|
法匹拉韋
|
259793-96-9
|
|
Imatinib
|
伊馬替尼
|
152459-95-5
|
|
VU6012962
|
VU6012962
|
|
|
AB-928
|
AB-928
|
2239273-34-6
|
|
AER-271
|
AER-271
|
634913-39-6
|
|
NVS-ZP7-4
|
NVS-ZP7-4
|
2349367-89-9
|
|
AWZ1066S
|
AWZ1066S
|
2239272-16-1
|
|
GSK8612
|
GSK8612
|
|
|
Spastazoline
|
SPASTAZOLINE
|
2351882-11-4
|
|
DS-1971a
|
DS-1971a
|
1450595-86-4
|
|
Ferric Carboxymaltos
|
羧基麥芽糖鐵
|
9007-72-1
|
|
ACH-4471
|
Danicopan
|
1903768-17-1
|
|
AZD-7648
|
AZD-7648
|
2230820-11-6
|
|
LML-134
|
LML-134
|
1542135-76-1
|
|
SR-4835
|
SR-4835
|
2387704-62-1
|
|
CA-4948
|
4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-
|
1801344-14-8
|
|
4-(Hydroxymethyl)cyclohexan-1-one
|
4-(羥甲基)環(huán)己酮
|
38580-68-6
|
|
ACH-000143
|
化合物ACH-000143
|
2225836-30-4
|
|
ε-Pyrrole-lysine
|
ε-吡咯賴氨酸
|
74509-14-1
|
|
Lesinurad Impurity B
|
雷西納德雜質(zhì)B
|
1533519-93-5
|
|
Licogliflozin
|
1291094-73-9
|
1291094-73-9
|
|
4-Bromo-2-methylbenzenemethanamine
|
4-溴-2-甲基苯甲胺
|
376646-62-7
|
|
2-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE
|
鹽酸芐替米特
|
5633-14-7
|
|
Tavapadon
|
他伐帕敦
|
1643489-24-0
|
|
AB680
|
AB-680
|
2105904-82-1
|
|
(1R,2R)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-2-methyl-8-azaspiro[4.5]decan-1-amine
|
(3S,4S)-8-(6-氨基-5-((2-氨基-3-氯吡啶基-4-基)硫代)吡嗪-2-基)-3-甲基-2-氧雜-8-氮雜螺[4.5]癸-4-胺
|
1801765-04-7
|
|
AT-007
|
AT-007
|
2170729-29-8
|
|
2-diphenylphosphanylbenzenethiol
|
2-(二苯基膦基)苯硫酚
|
119327-17-2
|
|
suvn-911
|
化合物SUVN-911
|
2414674-71-6
|
|
EST73502
|
化合物EST73502 HCL
|
2307458-82-6
|
|
XL-092
|
XL092
|
2367004-54-2
|